Bizily Scott's Form 4 filing
4D Molecular Therapeutics, Inc. (FDMT) · filed Jul 3, 2024
- Accession no.
- 0000950170-24-081626
- Filed
- Jul 3, 2024
- Trade date
- Jul 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $90.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bizily ScottCIK 0001920738 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | Common Stock | MOption exerciseAcquired | +1,332 | $6.49 | +$8,644.68 | 3,069 | Direct | |
| Jul 1, 2024 | Common Stock | MOption exerciseAcquired | +2,916 | $8.04 | +$23,444.64 | 5,985 | Direct | |
| Jul 1, 2024 | Common Stock | SSaleDisposed | −4,248 | $21.36 | −$90,737.28 | 1,737 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | Common Stock | MOption exerciseDisposed | −1,332 | $0.00 | $0 | 11,879 | Direct | |
| Jul 1, 2024 | Common Stock | MOption exerciseDisposed | −2,916 | $0.00 | $0 | 33,752 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.